Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010;1(2):91-3.

The impact of hepatitis B infection on outcome of kidney transplantation: a long-term study

B Einollahi  1 , S M Alavian  2 , M Lessan-Pezeshki  3 , N Simforoosh  4 , M H Nourbala  1 , Z Rostami  1 , V Pourfarziani  1 , E Nemati  1 , M Sharafi  1 , M Nafar  4 , F Pour-Reza Gholi  4 , A Firoozan  4
Affiliations

The impact of hepatitis B infection on outcome of kidney transplantation: a long-term study

B Einollahi et al. Int J Organ Transplant Med. 2010.

Abstract

Background: With the success of kidney transplantation, liver disease has emerged as an important cause of morbidity and mortality in kidney recipients.

Objective: To determine the impact of hepatitis B virus (HBV) infection on patients and graft survival in both short- and long-terms.

Methods: 99 renal transplant patients infected with HBV on follow-up in two major transplant centers were included in a retrospective study. These patients were grafted between 1986 and 2005 and divided into two groups: (1) those only positive for hepatitis B surface antigen (HBsAg) and (2) those who were also positive for hepatitis C virus antibodies (HCV Ab).

Results: There were 88 patients with HBsAg(+) and 11 with both HBsAg(+) and HCV Ab(+). The mean±SD age of patients was 38.8±13.2 years, and the median follow-up after transplantation was 19 months. Although not significant, the allograft survival rate in the first group (HBV(+)) was better compared to that in the second group (HBV(+) and HCV(+)); 1, 5 and 10 years graft survival rates were 91, 77 and 62 in the first group and 70, 56 and 28 in the second group, respectively (P=0.07). The overall mortality was 5% (4 of 88) in the first and 27% (3 of 11) in the second group (P=0.02).

Conclusion: Renal allograft recipients with HBV and HCV infections has a poor survival rate compared to patients with only HBV infection. However, there is no significant difference in terms of renal graft survival between the two groups.

Keywords: Hepatitis B virus; Hepatitis C virus; Kidney transplantation.

PubMed Disclaimer

References

    1. Alavian SM, Hajarizadeh B, Einollahi B. Efficacy and safety of lamivudine for treatment of chronic hepatitis B in renal allograft recipients. Transplant Proc. 2003;35:2687–8. - PubMed
    1. Morales JM. Renal transplantation in patients positive for hepatitis B or C (pro) Transplant Proc. 1998;30:2064–9. - PubMed
    1. Kliem V, Michel U, Burg M, et al. Geographical prevalence, risk factors and impact of hepatitis B and C after renal transplantation. Clin Nephrol. 2009;71:423–9. - PubMed
    1. Chan TM, Chapman J, Lee CJ, et al. A survey on the prevalence and management of hepatitis B after renal transplantation in Asian-Pacific countries. Transplant Proc. 2004;36:2126–7. - PubMed
    1. Rao KV, Kasiske BL, Anderson WR. Variability in the morphological spectrum and clinical outcome of chronic liver disease in hepatitis B-positive and B-negative renal transplant recipients. Transplantation. 1991;51:391–6. - PubMed

LinkOut - more resources